The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome Meeting Abstract


Authors: Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Meagher, R. C.; Maloy, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Ponce, D. M.; van den Brink, M. R. M.; Young, J. W.; Perales, M. A.
Abstract Title: The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452507116
PROVIDER: wos
Notes: Meeting Abstract: 3498 -- Source: Wos
MSK Authors
  1. Sergio Andres Giralt
    516 Giralt
  2. Doris Ponce
    129 Ponce
  3. Miguel-Angel Perales
    365 Perales
  4. Juliet N Barker
    224 Barker
  5. Guenther Koehne
    174 Koehne
  6. James W Young
    254 Young
  7. Richard O'Reilly
    480 O'Reilly
  8. Molly Anna Maloy
    123 Maloy
  9. Christina Cho
    36 Cho
  10. Richard Charles Meagher
    38 Meagher
  11. Patrick Dale Hilden
    82 Hilden
  12. Jonathan U Peled
    40 Peled